Fig. 6From: Nintedanib antiangiogenic inhibitor effectiveness in delaying adenocarcinoma progression in Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP)Protein level quantification on the ventral prostate lobe from different experimental groups. a VEGF (n = 3). b VEGFR-1 (n = 3). c FGFR-3 (n = 5). d AR (n = 3) and e ERα (n = 3). Values related to β-actin (endogenous control), compared between treated and its respective control group and expressed as media ± S.E.M. *p < 0.05; **p < 0.01Back to article page